Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Epigenetics of hepatocellular carcinoma: a new horizon.

Liu WR, Shi YH, Peng YF, Fan J.

Chin Med J (Engl). 2012 Jul;125(13):2349-60. Review.

PMID:
22882861
2.

Epigenetic mechanisms in hepatocellular carcinoma: how environmental factors influence the epigenome.

Herceg Z, Paliwal A.

Mutat Res. 2011 May-Jun;727(3):55-61. doi: 10.1016/j.mrrev.2011.04.001. Epub 2011 Apr 15. Review.

PMID:
21514401
3.

[DNA methylation in thyroid carcinoma].

Song X, Shang X, Zhang Y.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015 Mar;29(6):573-6. Chinese.

PMID:
26211174
4.
5.

New Insights into the Epigenetics of Hepatocellular Carcinoma.

Wahid B, Ali A, Rafique S, Idrees M.

Biomed Res Int. 2017;2017:1609575. doi: 10.1155/2017/1609575. Epub 2017 Mar 19. Review.

6.

Methylation and liver cancer.

Raggi C, Invernizzi P.

Clin Res Hepatol Gastroenterol. 2013 Dec;37(6):564-71. doi: 10.1016/j.clinre.2013.05.009. Epub 2013 Jun 24. Review.

PMID:
23806627
7.

Epigenetic mechanism involved in the HBV/HCV-related hepatocellular carcinoma tumorigenesis.

Rongrui L, Na H, Zongfang L, Fanpu J, Shiwen J.

Curr Pharm Des. 2014;20(11):1715-25. Review.

PMID:
23888939
8.

DNA methylation and hepatocellular carcinoma.

Zhu J.

J Hepatobiliary Pancreat Surg. 2006;13(4):265-73. Review.

PMID:
16858536
9.

[Progress of epigenetics and its therapeutic application in hepatocellular carcinoma].

Lingyun S, Xingyu L, Zhiwei S.

Yi Chuan. 2015 Jun;37(6):517-27. doi: 10.16288/j.yczz.14-443. Review. Chinese.

PMID:
26351047
10.

Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.

Pogribny IP, Rusyn I.

Cancer Lett. 2014 Jan 28;342(2):223-30. doi: 10.1016/j.canlet.2012.01.038. Epub 2012 Feb 2. Review.

11.

Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration.

Zhao W, Liu H, Liu W, Wu Y, Chen W, Jiang B, Zhou Y, Xue R, Luo C, Wang L, Jiang JD, Liu J.

Int J Oncol. 2006 May;28(5):1081-8.

PMID:
16596223
12.

Epigenetic methylation and expression of caspase 8 and survivin in hepatocellular carcinoma.

Cho S, Lee JH, Cho SB, Yoon KW, Park SY, Lee WS, Park CH, Joo YE, Kim HS, Choi SK, Rew JS.

Pathol Int. 2010 Mar;60(3):203-11. doi: 10.1111/j.1440-1827.2009.02507.x.

PMID:
20403046
13.

Current progress in epigenetic research for hepatocarcinomagenesis.

Huang J.

Sci China C Life Sci. 2009 Jan;52(1):31-42. doi: 10.1007/s11427-009-0014-7. Epub 2009 Jan 19. Review.

PMID:
19152082
14.

Epigenetic studies in human diseases.

Haluskov√° J.

Folia Biol (Praha). 2010;56(3):83-96. Review.

15.

Expression of a novel gene FAM43B repressing cell proliferation is regulated by DNA methylation in hepatocellular carcinoma cell lines.

Xu X, Liu RF, Wan BB, Xing WM, Huang J, Han ZG.

Mol Cell Biochem. 2011 Aug;354(1-2):11-20. doi: 10.1007/s11010-011-0800-y. Epub 2011 Apr 2.

PMID:
21461611
16.
17.

Genetic and epigenetic changes in fibrosis-associated hepatocarcinogenesis in mice.

Chappell G, Kutanzi K, Uehara T, Tryndyak V, Hong HH, Hoenerhoff M, Beland FA, Rusyn I, Pogribny IP.

Int J Cancer. 2014 Jun 15;134(12):2778-88. doi: 10.1002/ijc.28610. Epub 2013 Dec 14.

18.

Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.

Lim SO, Gu JM, Kim MS, Kim HS, Park YN, Park CK, Cho JW, Park YM, Jung G.

Gastroenterology. 2008 Dec;135(6):2128-40, 2140.e1-8. doi: 10.1053/j.gastro.2008.07.027. Epub 2008 Jul 31.

PMID:
18801366
19.

Epigenetic instability and chromosomal instability in hepatocellular carcinoma.

Katoh H, Shibata T, Kokubu A, Ojima H, Fukayama M, Kanai Y, Hirohashi S.

Am J Pathol. 2006 Apr;168(4):1375-84.

20.

Detection of epigenetic aberrations in the development of hepatocellular carcinoma.

Zhang Y.

Methods Mol Biol. 2015;1238:709-31. doi: 10.1007/978-1-4939-1804-1_37. Review.

PMID:
25421688

Supplemental Content

Support Center